speb/financial-data huggingface dataset:
BAFNAPH.NS income_statement (annual, 2024-03-31) — Interest Expense: 19375000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 19375000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Interest Income: 1253000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 1253000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -23108000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 1235000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Inventories Adjustments Allowances: 0.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Inventory: 296418000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 1052280000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -150536000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 6993000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1932000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 107532000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 107532000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 3917000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 592894000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Net Debt: 229933000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Net Income: 73479000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 73479000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 73479000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 73479000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 73479000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 73479000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 73479000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -2700000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Net Interest Income: -21650000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 0.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 14654000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 14654000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -21650000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 5000000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Net PPE: 507074000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -154071000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 790687000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 16147000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 7345000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 142898000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Normalized Income: 73569000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 94848000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Operating Income: 65269000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Operating Revenue: 1524657000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 23656335.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 166057000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 18272000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 571827000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 17700000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 20606000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -2000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 3000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 13232000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 54186000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Payable: 32825000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Properties: 148530000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 842000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 6993000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Other Special Charges: -657000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Payables: 389206000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 18676000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Pretax Income: 73479000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 5251000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -2700000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: 0.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -155782000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 174477000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 1069072000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 49954000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 2099000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 2099000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Research And Development: 2665000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -470990000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 1711000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 6010000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 94018000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Share Issued: 23656335.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Special Income Charges: -90000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 808387000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 790687000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Tax Provision: 0.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 153862000.00
BAFNAPH.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -1737000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Total Assets: 1476816000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 915919000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Total Debt: 243893000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 808387000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Total Expenses: 1459388000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 668429000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 539112000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 127599000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 3528000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 2158000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -90000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -90000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Work In Process: 91292000.00
BAFNAPH.NS balance_sheet (annual, 2024-03-31) — Working Capital: 396876000.00
BAFNAPH.NS income_statement (annual, 2024-03-31) — Write Off: 747000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 228700000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 337150000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 8016000.00
BAFNAPH.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 23580180.00
BAFNAPH.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 1.11
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 236563000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 13147000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 13218000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 236563000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 827509000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 15656000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 746115000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 74996000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 74996000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 380011000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 12620000.00
BAFNAPH.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 23580180.00
BAFNAPH.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 1.11
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 17700000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 555255000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 274712000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 1015741000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 8016000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 113236000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 113236000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 5691000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 175085000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 555255000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 809809000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Revenue: 15152000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 23656335.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 113152000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 23596000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 590946000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 17700000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 539599000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 698000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 71000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Payables: 228700000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 23656335.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 827509000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 809809000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 7185000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 1341599000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 940745000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 188232000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 827509000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 514090000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 595484000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 134079000.00
BAFNAPH.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 366104000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 81562000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 331876000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 23692500.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 0.40
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 236259000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 16557000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 16557000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 23692500.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.40
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 9477000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — EBIT: 15831000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — EBITDA: 32388000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 95617000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 6354000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 6354000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Net Income: 9477000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 9477000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 9477000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 9477000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 9477000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 9477000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -6354000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -6354000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 32508000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 9597000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Operating Income: 14055000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 331876000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 1896000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 12433000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Other Special Charges: 120000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 9477000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 236259000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 16557000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: -120000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 0.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 317821000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: -120000.00
BAFNAPH.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -120000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — +Operating Expense: 365088000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 95801000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — +Total Revenue: 1458570000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 390600000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 309452000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 309452000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 401735000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 401735000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -467477000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -467477000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 753765000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 753765000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -5928000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -5928000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 14513000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 14513000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 5000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 5000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 23593750.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 23836364.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Basic EPS: 1.76
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.55
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 13960000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 275101000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 275101000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -218597000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 236563000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 236563000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 34327000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 34327000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 34327000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 34327000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 34139000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 34139000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 188000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 188000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 11802000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 37221000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 15415000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Change In Payable: -44773000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 55628000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 75488000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 20367000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Common Stock: 236563000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 236563000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 848065000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 848065000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 73132000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 73132000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 1030610000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 265830000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Current Assets: 847276000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 847276000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Current Debt: 141701000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 141701000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 141701000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 141701000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 518517000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 518517000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 13830000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 13830000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Depreciation: 48897000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 48897000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 48897000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2151000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 48897000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 2151000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 23593750.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 23836364.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Diluted EPS: 1.76
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.55
BAFNAPH.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 41525000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 13110000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — EBIT: 68838000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — EBIT: 21332000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — EBITDA: 117735000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — EBITDA: 23483000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — End Cash Position: 34327000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 10637000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 19270000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 19270000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 2762000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 744000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 27317000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 0.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 407663000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 407663000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 1128410000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 660931000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Gross Profit: 427960000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 124770000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Interest Expense: 27313000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 8222000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 27313000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 8222000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Interest Income: 1364000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 1364000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -27456000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 1387000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Inventory: 280861000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 280861000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 1130051000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1130051000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -211629000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 5000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 5000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1932000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1932000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 140285000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 140285000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 140285000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 140285000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 4782000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 4782000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 586058000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 586058000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Net Debt: 247659000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 247659000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Net Income: 41525000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Net Income: 13110000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 41525000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 13110000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 41525000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 13110000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 41525000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 13110000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 41525000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 13110000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 41525000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 41525000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 13110000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: 0.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Net Interest Income: -27313000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -8222000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -5000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 38093000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 38093000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -27313000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -8222000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 5000000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Net PPE: 660933000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 660933000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -218011000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 848065000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 848065000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 19142000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 19142000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 8066000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 8066000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 139191000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 41370000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Normalized Income: 62981000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 30997000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 221359000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Operating Income: 62872000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Operating Income: 28969000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Operating Revenue: 1458570000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 390600000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 23656335.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 23656335.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 127144000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 127144000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 26039000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 26039000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 611502000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 611502000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 46067000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 27422000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 10250000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 105894000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 37839000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Other Payable: 41828000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 41828000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Other Properties: 192187000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 192187000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 230000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 230000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Other Special Charges: 19873000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Other Special Charges: 16303000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Payables: 309452000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Payables: 352927000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 21766000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 21766000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Pretax Income: 41525000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 13110000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 4953000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: 0.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -5000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -218597000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 223385000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 223385000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 1030610000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 265830000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 48897000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2151000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 2253000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 2253000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Research And Development: 14541000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -431312000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -431312000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 586000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 3494000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 30811000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Share Issued: 23656335.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 23656335.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Special Income Charges: -21456000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: -17887000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 848065000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 848065000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 848065000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 848065000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Tax Provision: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 108357000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 108357000.00
BAFNAPH.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 3503000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Total Assets: 1530791000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1530791000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 988350000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 988350000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Total Debt: 281986000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 281986000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 848065000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 848065000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Total Expenses: 1395698000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 361631000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 682726000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 682726000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 683517000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 683517000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 164209000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 164209000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 1692000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 1647000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 1647000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -21456000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: -17887000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -21456000.00
BAFNAPH.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -17887000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Work In Process: 38206000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 38206000.00
BAFNAPH.NS balance_sheet (annual, 2025-03-31) — Working Capital: 328759000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 328759000.00
BAFNAPH.NS income_statement (annual, 2025-03-31) — Write Off: 182000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 85075000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 346240000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 23698601.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.43
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 224178000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 13699000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 13699000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 23698601.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.43
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 33889000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — EBIT: 42943000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — EBITDA: 56642000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 122062000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 9054000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 9054000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Net Income: 33889000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 33889000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 33889000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 33889000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 33889000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 33889000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -9054000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -9054000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 56642000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 33889000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Operating Income: 36987000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 346240000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 5956000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 14977000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 33889000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 224178000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 13699000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 309253000.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 95971000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 354682000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 260235000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 325661000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 0.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 9494000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 23673485.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.32
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 236563000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2544000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 19670000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 236563000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 912279000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 146666000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 230615000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 800658000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 130737000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 130737000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 478161000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 16255000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 14727000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 14727000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 23673485.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.32
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 31249000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — EBIT: 39892000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — EBITDA: 54619000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 0.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 796675000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 124067000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 8643000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 8643000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 309986000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1236307000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 9494000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 193291000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 193291000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 4782000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 321484000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Net Income: 31249000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 31249000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 31249000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 31249000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 31249000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 31249000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -8643000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -8643000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 796675000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 912279000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 18314000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 54619000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 31249000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Operating Income: 28096000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 354682000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 23656335.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 140883000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 40201000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 675716000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 11797000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 26339000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 650009000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1081000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 17126000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Payables: 260235000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 31249000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 230615000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 14727000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 23656335.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 912279000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 912279000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 3377000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 1606827000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1105570000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 324028000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 912279000.00
BAFNAPH.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 326586000.00
BAFNAPH.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 694548000.00